Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomaterials

• Publication date

  2011-03-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.biomaterials.2010.11.035PMID 21147500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening for prostate cancer.

  2013cited by this paper
• Screening for prostate cancer.

  2011cited by this paper
• Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells.

  2010cited by this paper
• Simultaneous electrochemical detection of both PSMA (+) and PSMA (-) prostate cancer cells using an RNA/peptide dual-aptamer probe.

  2010cited by this paper
• Detection for folding of the thrombin binding aptamer using label-free electrochemical methods.

  2008cited by this paper
• A sandwich structured SiO(2)/cytochrome c/SiO(2) on a boron-doped diamond film electrode as an electrochemical nitrite biosensor.

  2008cited by this paper
• A simple and direct electrochemical detection of interferon-gamma using its RNA and DNA aptamers.

  2008cited by this paper
• Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.

  2008cited by this paper
• Partition identities and Ramanujan's modular equations

  2007cited by this paper
• Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.

  2007cited by this paper
• Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.

  2007influential reference
• Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

  2007cited by this paper
• Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging.

  2006cited by this paper
• Electrochemical detection of mismatched DNA using a MutS probe

  2006cited by this paper
• Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging

  2006cited by this paper
• Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

  2006cited by this paper
• Aptamer:toxin conjugates that specifically target prostate tumor cells.

  2006cited by this paper
• Aptamers selected for higher-affinity binding are not more specific for the target ligand.

  2006cited by this paper
• An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform.

  2006cited by this paper
• Molecular Imaging in Cancer

  2006cited by this paper
• Nanomedicine: developing smarter therapeutic and diagnostic modalities.

  2006cited by this paper
• Recent advances in iron oxide nanocrystal technology for medical imaging.

  2006cited by this paper
• Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

  2006cited by this paper
• A gold nanoparticles/sol-gel composite architecture for encapsulation of immunoconjugate for reagentless electrochemical immunoassay.

  2006cited by this paper
• Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system

  2005cited by this paper
• Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness.

  2005cited by this paper
• Functionalized conducting polymer as an enzyme-immobilizing substrate: an amperometric glutamate microbiosensor for in vivo measurements.

  2005cited by this paper
• Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.

  2005cited by this paper
• Electrochemical antitumor drug sensitivity test for leukemia K562 cells at a carbon-nanotube-modified electrode.

  2005cited by this paper
• Aptamers—basic research, drug development, and clinical applications

  2005cited by this paper
• Aptamers: an emerging class of therapeutics.

  2005cited by this paper
• Use of DNA repair enzymes in electrochemical detection of damage to DNA bases in vitro and in cells.

  2005cited by this paper
• Screening for prostate cancer.

  2005cited by this paper
• A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.

  2005cited by this paper
• Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery

  2004cited by this paper
• Prostate Cancer Diagnosis, Staging and Survival

  2004cited by this paper
• Detection of protein-DNA interaction with a DNA probe: distinction between single-strand and double-strand DNA-protein interaction.

  2004cited by this paper
• Redox-active star molecules incorporating the 4-benzoylpyridinium cation: implications for the charge transfer efficiency along branches vs across the perimeter in dendrimers.

  2004cited by this paper
• Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

  2004cited by this paper
• Use of polymeric indicator for electrochemical DNA sensors: poly(4-vinylpyridine) derivative bearing [Os(5,6-dimethyl-1,10-phenanthroline)2Cl]2+.

  2004cited by this paper
• Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.

  2004cited by this paper
• Development of a new and simple method for the detection of histidine-tagged proteins.

  2004cited by this paper
• Drug Delivery Systems: Entering the Mainstream

  2004cited by this paper
• Advancing the field of drug delivery: taking aim at cancer.

  2003cited by this paper
• Lysophosphatidic acid‐regulated mitogenic ERK signaling in androgen‐insensitive prostate cancer PC‐3 cells

  2002cited by this paper
• Electrochemistry of Nucleic Acids and Development of DNA Sensors

  2002cited by this paper
• Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

  2002cited by this paper
• Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour.

  2002cited by this paper
• Biodegradable polymeric nanoparticles as drug delivery devices.

  2001cited by this paper
• Escort aptamers: a delivery service for diagnosis and therapy.

  2000cited by this paper
• Site-specific labeling of RNA with fluorophores and other structural probes.

  1999cited by this paper
• Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP).

  1999cited by this paper
• Electrochemical biosensors for DNA hybridization and DNA damage.

  1998cited by this paper
• Prostate‐specific membrane antigen

  1997cited by this paper
• Biodegradable block copolymers as injectable drug-delivery systems

  1997cited by this paper
• Site–Specific (Targeted) Drug Delivery in Cancer Therapy

  1983cited by this paper
• Electrical stimulation with Pt electrodes. V. The effect of protein on Pt dissolution.

  1980cited by this paper

• Uncovering Novel Susceptible Genes and Therapeutic Targets of Prostate Cancer: a Multi-omics Study Integrating Summary-based Mendelian Randomization Analysis and Molecular Docking

  2025cites this paper
• Aptamers as a new frontier in targeted cancer therapy.

  2025cites this paper
• Aptamers as therapeutic targets: prospects and progress in the treatment of cancers.

  2025cites this paper
• Nanotherapeutics for prostate cancer treatment: A comprehensive review.

  2024cites this paper
• Selection of a nickel-specific DNA aptamer and development of a protocol for radioactive nickel removal

  2024cites this paper
• RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions

  2023cites this paper
• Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications

  2023cites this paper
• Tumor Abnormality-Oriented Nanomedicine Design.

  2023cites this paper
• An Aptamer-Embedded Two-Dimensional DNA Nanoscale Material with the Property of Cells Recruitment.

  2023cites this paper
• Molecular MR Imaging of Prostate Cancer by Specified Iron Oxide Nanoparticles With PSMA‐11 Peptides: A Preclinical Study

  2023cites this paper
• NIR-II-triggered photothermal therapy with Au@PDA/PEG-PI for targeted downregulation of PSMA in prostate cancer.

  2022cites this paper
• Insights into Aptamer–Drug Delivery Systems against Prostate Cancer

  2022cites this paper
• Preparation and characterization of DNA aptamers against roxithromycin.

  2021cites this paper
• Aptamers for Personalized Therapeutics

  2021cites this paper
• Co-delivery of simvastatin and demineralized bone matrix hierarchically from nanosheet-based supramolecular hydrogels for osteogenesis.

  2021cites this paper
• Tumor imaging and its applications in tumor-targeted drug delivery

  2021cites this paper
• Targeted delivery of doxorubicin through CD44 aptamer to cancer cells.

  2021cites this paper
• Recent advances in engineering iron oxide nanoparticles for effective magnetic resonance imaging

  2021cites this paper
• Nanomedicines: Recent Progress, Impact and Challenges in Applications

  2021cites this paper
• Past, present, and future trends in boar taint detection

  2021cites this paper
• Aptamer-Modified Nanoparticles in Medical Applications.

  2020cites this paper
• Aptamer-navigated copolymeric drug carrier system for in vitro delivery of MgO nanoparticles as insulin resistance reversal drug candidate in Type 2 diabetes

  2020cites this paper
• Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy

  2020cites this paper
• A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy

  2019cites this paper
• Aptamer: Apt System for Target-Specific Drug Delivery

  2019cites this paper
• Polymeric Nanoparticulates as Efficient Anticancer Drugs Delivery Systems

  2019cites this paper
• Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications—The Role of Molecular Dynamics Simulation

  2019cites this paper
• Design and characterization of a multi‐layered polymeric drug delivery vehicle

  2019cites this paper
• Aptamers: Biotechnological Applications of a Next Generation Tool

  2019cites this paper
• A Rapid Colorimetric Sensor for Soluble Interleukin‐2 Receptor α, Based on Aptamer‐Adsorbed AuNP

  2019cites this paper
• A dual-targeted nucleic acid moiety decorated SPION nanoparticles for chemo-photodynamic synergistic therapy

  2019cites this paper
• Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting

  2019cites this paper
• Process evaluation and in vitro selectivity analysis of aptamer-drug polymeric formulation for targeted pharmaceutical delivery.

  2018cites this paper
• Magnetic Resonance Imaging‐Guided Drug Delivery to Breast Cancer Stem‐Like Cells

  2018cites this paper
• Challenges of SELEX and Demerits of Aptamer-Based Methods

  2018cites this paper
• Aptamer as capture agent in enzyme‐linked apta‐sorbent assay (ELASA) for ultrasensitive detection of Aflatoxin B1

  2018cites this paper
• Tethered imidazole mediated duplex stabilization and its potential for aptamer stabilization

  2018cites this paper
• Biophysical characterization of layer‐by‐layer synthesis of aptamer‐drug microparticles for enhanced cell targeting

  2018cites this paper
• Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer

  2018cites this paper
• Aptamer-Patterned Hydrogel Films for Spatiotemporally Programmable Capture and Release of Multiple Proteins.

  2018cites this paper
• Development of Aptamer-Based Lateral Flow Assay Methods

  2018cites this paper
• Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents

  2018cites this paper
• Development of transferrin receptor aptamers as drug delivery vehicles for the treatment of brain metastases

  2018cites this paper
• Development of RNA aptamers and synthetic riboswitch using Capture-SELEX

  2018cites this paper
• Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities

  2018cites this paper
• A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.

  2018cites this paper
• Targeted and theranostic applications for nanotechnologies in medicine

  2017cites this paper
• ABCs of DNA aptamer and related assay development.

  2017cites this paper
• Applications of Magnetic Nanomaterials in Biosensors and Diagnostics

  2017cites this paper
• Towards targeted cancer therapy: Aptamer or oncolytic virus?

  2017cites this paper
• Impacts of Aptamer Technology on Diagnostics, Biotechnology, and Therapy

  2017cites this paper
• Aptamer Technology in the Targeted Delivery of Doxorubicin

  2017cites this paper
• Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer

  2017cites this paper
• Nanotechnology: An Evolution in Tissue Preservation and Focal-Targeted Oncologic Therapy

  2017cites this paper
• Chapter 3 Aptamers : Promising Molecules for Diagnosis and Treatment of Prostate Cancer

  2016cites this paper
• The use of oligonucleotide aptamers in cancer therapy

  2016cites this paper
• Aptamer–nanoparticle complexes as powerful diagnostic and therapeutic tools

  2016cites this paper
• Magnetic‐Nanoparticle‐Based Immunoassays‐on‐Chip: Materials Synthesis, Surface Functionalization, and Cancer Cell Screening

  2016cites this paper
• A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery

  2016cites this paper
• Nanoparticle-mediated delivery of suicide genes in cancer therapy.

  2016cites this paper
• Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers

  2016cites this paper
• Aptamer-Mediated Targeted Delivery of Therapeutics: An Update

  2016cites this paper
• Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.

  2016cites this paper
• Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon.

  2016cites this paper
• [The use of oligonucleotide aptamers in cancer therapy].

  2016cites this paper
• Methods for Improving Aptamer Binding Affinity

  2016cites this paper
• A highly sensitive and selective impedimetric aptasensor for interleukin-17 receptor A.

  2016cites this paper
• Aptamer-Mediated Selective Protein Affinity to Improve Scaffold Biocompatibility

  2016cites this paper
• Multimodal imaging probe for targeting cancer cells using uMUC-1 aptamer.

  2015cites this paper
• Design and Application of Rolling Circle Amplification for a Tumor-Specific Drug Carrier.

  2015cites this paper
• Theophylline detection in serum using a self-assembling RNA aptamer-based gold nanoparticle sensor.

  2015cites this paper
• β-Conglutin dual aptamers binding distinct aptatopes

  2015cites this paper
• Prostate-specific membrane antigen as a target for cancer imaging and therapy.

  2015cites this paper
• NANO-SIZED DRUG DELIVERY PLATFORMS FOR TAXANE ANTINEOPLASTIC AGENTS

  2015cites this paper
• Comparison of Drug Delivery Efficiency between Doxorubicin Intercalated in RNA Aptamer and One Encapsulated in RNA Aptamer- Conjugated Liposome

  2015cites this paper
• Aptamers in targeted nanotherapy.

  2015cites this paper
• Advanced Micro-Nano-Bio Systems for Future Targeted Therapies

  2015cites this paper
• Nanocapsules in Biomedicine: Promises and Challenges

  2015cites this paper
• Nucleic acid-based aptamers: applications, development and clinical trials.

  2015cites this paper
• Preparation of magnetically responsive albumin nanospheres and in vitro drug release studies

  2014cites this paper
• DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer

  2014cites this paper
• RNA Aptamer Technology

  2014cites this paper
• Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice.

  2014cites this paper
• Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo

  2014cites this paper
• Progress in Aptamer-Mediated Drug Delivery Vehicles for Cancer Targeting and Its Implications in Addressing Chemotherapeutic Challenges

  2014cites this paper
• Cationic Surfactant-Based Colorimetric Detection of Plasmodium Lactate Dehydrogenase, a Biomarker for Malaria, Using the Specific DNA Aptamer

  2014cites this paper
• Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

  2014cites this paper
• RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.

  2014cites this paper
• Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.

  2014cites this paper
• Progress in selection and biomedical applications of aptamers.

  2014cites this paper
• Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges

  2014cites this paper
• Combinatorial peptide libraries: mining for cell-binding peptides.

  2014cites this paper
• Microfluidic chip integrated with flexible PDMS-based electrochemical cytosensor for dynamic analysis of drug-induced apoptosis on HeLa cells.

  2014cites this paper
• Aptamer-conjugated magnetic nanoparticles enable efficient targeted detection of integrin αvβ3 via magnetic resonance imaging.

  2014cites this paper
• Magnetic separation techniques in sample preparation for biological analysis: a review.

  2014cites this paper
• Molecular insights and oligonucleotide based targeted gene therapy against cancer

  2014cites this paper
• CNT MEMBRANE PLATFORMS FOR TRANSDERMAL DRUG DELIVERY AND APTAMER MODULATED TRANSPORT

  2014cites this paper
• Ultra-effective photothermal therapy for prostate cancer cells using dual aptamer-modified gold nanostars.

  2014cites this paper
• Aptamers as Drug Delivery Vehicles

  2014cites this paper
• Diseases originate and terminate by genes: unraveling nonviral gene delivery

  2013cites this paper